Our 39th annual course will once again focus on themes that showcase recent results in evidence-based medicine that have been reported in the last year or two and have an impact on clinical practice. These will include a wide spectrum of interests related to cardiologic subspecialties, such as artificial intelligence, heart failure, arrhythmias, cardiac surgery, gene therapy, and aortic disorders.

Distinguished visiting academicians from North America will be joining our faculty, together with exceptional educators and physicians from the University of California, San Francisco.

Thirty days after the course, participants will be able to watch all of the recorded sessions online.

TARGET PUBLIC
The target audience for this course includes cardiologists in practice, internists, family doctors, and cardiovascular

Goals:

giving optimal care for heart failure (systolic and diastolic), hypertension, lipid problems, diabetes, atrial fibrillation and flutter, STEMI and non-STEMI, and thromboembolic disease
Refinement factors for ablation of ventricular tachycardia, atrial fibrillation, and atrial flutter
Utilising percutaneous intervention or surgical revascularization as the optimal treatment options for coronary heart disease
Understanding the risk factors associated with cardiovascular disease
Improving the way that ascending thoracic aorta disease is managed
Improving pulmonary embolism treatment
Understanding the function of heart surgery in endocarditis treatment
Understanding the hereditary roots of cardiovascular disorders
Realising the value of profound empathy in relationships with patients
Realising that different racial and ethnic groups have different illness pathophysiologies and available treatments
Improving the way cardiac amyloidosis is managed
Understanding the relationship between the heart and the mind Understanding how air pollution affects cardiovascular health
Course Description:

December 2, 2022, Friday
7 a.m.Check-in and breakfast provided by Continental
8 a.m.Greetings and SynopsisDr. Peter Ganz
Session: Cutting Edges in Cardiology: Deep Empathy, AI, and GeneticsChairperson: Dr. Priscilla Hsue
8:15 a.m.The Mind-Heart Link: Stress and Trauma as Risk Factors for Cardiovascular DiseaseTawakol, Ahmed M.
8:55 a.m.Cardiological Artificial IntelligenceDr. Geoff Tison, MPH
9.35 a.m.Thoracic Aortic Aneurysms that Ascend: Assessment, Treatment, and Genetic TestingDr. Lisa Wilsbacher, Ph.D.
10.15 a.m.10:30 a.m. is coffee break.A Transthyretin Amyloidosis UpdateDr. Mandar Aras, PhD
11:00 a.m.Where Are We with Gene Targeting for Cardiometabolic Diseases?Dr. John Chorba
11:50 a.m.Rapaport, Elliott Keynote Address: Deep Empathy Medicine for High PerformanceDr. Eric Topol
12:40 a.m.Lunch (Alone)
Modern Cardiovascular Interventions: A SessionMD, MS Lucas Zier is the chair.
2:00 p.m.Novel Methods of Treating Pulmonary EmbolismDr. Gregory Piazza, M.S.
2:40 p.m.Physiological Evaluation of Coronary Stenosis Severity in the Cath Lab and by CT AngiographyDr. William Fearon
3:20 p.m.Increasing the Number of Options for Endocarditis ManagementDr. Amy Fiedler, MS
Bolger, Ann M.
4:00 at night.4:15 PM is coffee break time.Surgical Methods for Severe Heart FailureDr. Jason Smith
4:55 p.m.Revascularization in Stable Coronary Illness: Reviewing the DataDoctor Jeffrey Zimmet, Ph.D.
5:35 p.m.Dismiss
December 3, 2022, a Saturday
7.30 a.m.Continental Morning Meal
8 a.m.StatementsDr. Peter Ganz
Session: Electrophysiology: Progress and DebatesMD Nora Goldschlager is the chair.
8 a.m.What Will 2022 Mean for Sudden Cardiac Death?Dr. Zian Tseng, MAS
8:50 a.m.ECG Results Indicating a High Risk of ArrhythmiaDr. Melvin Scheinman
nine in the morning.Debate: For patients with symptomatic AFib, AFib ablation ought to be the first line of treatmentAdam Lee, M.D.
Tommy Dewland, M.D.
10 a.m.Coffee Break
10:25 a.m.Developments in Cardiac Imaging for the Aetiology, Prognosis, and Treatment of ArrhythmiasMD, MS Edward Gerstenfeld
11:00 a.m.Alcohol, Exercise, and Lifestyle Factors Associated with Atrial FibrillationMarcus Gregory, M.D., MAS
11:45 a.m.: Novel/Genetic Arrhythmia InterventionsPhD candidate Vasanth Vedantham
12:25 p.m.Debate: Prophylactic Primary Prevention ICD for Heart Failure in Dilated CardiomyopathyDr. Byron Lee, M.S.
Joshua Moss, M.D., M.S.
1:05 p.m.Lunch (alone)
Managing Heart Failure SessionJonathan Davis, MD, MPHS, is the chair.
2:10 p.m.Heart-related ShockJaya Mallidi, M.D.
3:00 p.m.HFrEF’s New Heart Failure Guidelines3:40 p.m. Jonathan Davis, MD, MPHS.New Guidelines for HFpEF Heart Failure4:20 p.m. Jonathan Davis, MD, MPHS.Coffee Break
4:35 p.m.Medication Costs and Polypharmacy in Guideline-Directed Medical Therapy for HFrEFPharmD Anusha McNamara
PharmD Rose Pavlakos
5:15 p.m.Remote Patient Monitoring for Patients withLiviu Klein, M.D., MS
Heart-related Conditions
5:55 p.m.Dismiss
December 4, 2022, Sunday
7.30 a.m.Continental Morning Meal
8 a.m.StatementsDr. Peter Ganz
Chair: Cardiovascular Risk Management Session: Dr. Binh An P. Phan
8 a.m.The Impact of Consuming Salt and Salt Substitutes on Clinical Results in Heart Failure and HypertensionMichael Crawford, Ph.D.
8:45 a.m.Managing Seniors’ Cardiovascular RiskDr. Carlin Long
9:25 a.m.Present-Day Cholesterol Guidelines: Debates and ConsensusDr. Peter Ganz
10:05 a.m.Regarding Non-Statin Lipid Modifying Therapy, Where Are We Now?Dr. Jorge Plutzky
10:45 a.m.Controlling Cardiovascular Risk and the Advancement of Chronic Kidney Disease in Diabetes PatientsDr. Lisa Murphy, PhD
11:25 a.m.Air pollution’s effects on cardiovascularResults for Karol Watson, MD, PhD
12:05 p.m.Dismiss

See also: